Physician profile
James Clark
NPI 1154954758
$2,989.04
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $95.04 · 2021: $1,009 · 2022: $1,171 · 2023: $544 · 2024: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $984.46 | 2020-2023 | Rinvoq, Skyrizi, Humira |
| Amgen INC. | $833.45 | 2020-2024 | Evenity, Enbrel, Otezla |
| Ucb, INC. | $237.80 | 2022-2023 | Cimzia |
| Lilly USA, LLC | $191.16 | 2021-2023 | Taltz |
| Glaxosmithkline, LLC. | $149.57 | 2022-2023 | Benlysta |
| Biodelivery Sciences International, INC. | $122.52 | 2021 | |
| Novartis Pharmaceuticals Corporation | $72.48 | 2021-2023 | |
| Fresenius Kabi USA, LLC | $47.69 | 2023 | |
| Almatica Pharma LLC | $42.07 | 2021 | |
| Mallinckrodt Hospital Products INC. | $39.16 | 2021 | |
| Sobi, INC | $36.38 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $35.66 | 2022 | |
| Janssen Biotech, INC. | $25.72 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $25.27 | 2023 | Uptravi, Opsumit |
| Orthogenrx INC. | $22.42 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $22.23 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $21.19 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.63 | 2021 | |
| Qiagen, LLC | $15.86 | 2022 | |
| Collegium Pharmaceutical, INC. | $15.16 | 2021 | |
| Avanos Medical | $14.75 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.